Evidence map›Paper›PMID 31934139›Full record

ArticleInternational journal of clinical and experimental pathology2019

Thyroid metastasis from non-small cell lung cancer.

Jun Cao, Yan-Er Yu, Ning-Ning Li, Yuan-Xi Wu, Jia-Ni Shi, Mei-Yu Fang

Abstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  6. Article
  7. Thyroid metastasis revealing a lung adenocarcinoma.Respiratory medicine case reports · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jun CaoDepartment of Comprehensive Medical Oncology, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital Hangzhou, China.
Yan-Er YuSecond Clinical Medical College, Zhejiang Chinese Medical University Hangzhou, Zhejiang, China.
Ning-Ning LiDepartment of Pathology, Zhejiang Cancer Hospital Hangzhou, Zhejiang, China.
Yuan-Xi WuSecond Clinical Medical College, Zhejiang Chinese Medical University Hangzhou, Zhejiang, China.
Jia-Ni ShiThird Clinical Medical College, Zhejiang Chinese Medical University Hangzhou, Zhejiang, China.
Mei-Yu FangDepartment of Comprehensive Medical Oncology, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-thyroid malignancies to the thyroid gland resulting from distant metastases are extremely rare, and such cases are rarely seen in clinical settings. The question of how a tumor metastasizes to the thyroid remains unanswered. Here we report a case of lung adenocarcinoma metastasizing to the thyroid gland. The article covers the pathological features, treatments, examination reports, and the postoperative follow-up reviews of the patient. In this article, we discuss the diagnostic method, the spread route, the prognosis, the mechanism and above all, the treatment. In addition, we searched the PubMed and ISI Web of Science databases for articles published in English using the key words "lung", "thyroid", and "metastasis", and we reviewed nearly all the reports about thyroid malignancies being metastasized from lung cancer. This rare case emphasizes the importance of the multifaceted comprehensiveness of the cephalometry diagnosis, pathological diagnosis, and immunohistochemical analysis to ensure that such rare cases are not missed. We declare that all cases of thyroid malignancies metastasized from the lungs shall be reported at large for further clinical research.

Indexed as

adenocarcinomanon-small cell lung cancerThyroid metastasis

Identifiers

PMID31934139
PMCPMC6949701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.